CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 251 filers reported holding CYTOKINETICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $603,153 | -15.9% | 21,505 | 0.0% | 0.12% | -22.0% |
| Q2 2023 | $717,407 | -27.2% | 21,505 | 0.0% | 0.16% | -57.4% |
| Q4 2022 | $985,359 | -7.2% | 21,505 | +3.6% | 0.37% | +43.5% |
| Q3 2022 | $1,062,000 | +19.3% | 20,755 | -4.6% | 0.26% | +33.3% |
| Q2 2022 | $890,000 | +11.1% | 21,755 | 0.0% | 0.20% | +25.0% |
| Q1 2022 | $801,000 | -19.4% | 21,755 | 0.0% | 0.16% | -9.3% |
| Q4 2021 | $994,000 | +18.2% | 21,755 | 0.0% | 0.17% | +12.4% |
| Q3 2021 | $841,000 | +97.9% | 21,755 | 0.0% | 0.15% | +84.3% |
| Q2 2021 | $425,000 | -16.3% | 21,755 | 0.0% | 0.08% | -22.4% |
| Q1 2021 | $508,000 | +20.7% | 21,755 | 0.0% | 0.11% | +11.5% |
| Q4 2020 | $421,000 | +1.9% | 21,755 | -11.4% | 0.10% | -14.3% |
| Q3 2020 | $413,000 | +184.8% | 24,555 | +102.0% | 0.11% | -21.1% |
| Q1 2020 | $145,000 | – | 12,155 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |